AIMC Topic: Schizophrenia

Clear Filters Showing 11 to 20 of 327 articles

Multi-omics reveal critical roles of phosphatidylcholine and sphingomyelin in antipsychotic efficacy for schizophrenia.

Signal transduction and targeted therapy
Nearly 30% of patients with schizophrenia respond inadequately to current antipsychotics, with unclear markers and mechanisms of antipsychotic efficacy. A total of 208 patients with schizophrenia treated for 6 weeks with oral paliperidone were analyz...

Voice as a digital biomarker in schizophrenia: a scoping review protocol on the application of artificial intelligence.

BMJ open
INTRODUCTION: There are many barriers to mental health services, including cost and stigma. Even when individuals receive professional care, assessments are intermittent and may be limited in part by the cyclical nature of psychiatric symptoms. The h...

Novel electroencephalographic biomarkers for the prediction of responders to an experimental glutamatergic agent in patients with schizophrenia.

Translational psychiatry
All medications currently used to treat schizophrenia, which exert their therapeutic effects by inhibiting dopaminergic neurotransmission, have their greatest efficacy against the positive symptoms of schizophrenia but have limited impact on negative...

Natural lithium isotope variations in serum after lithium administration as a novel biomarker for differentiating schizophrenia and bipolar disorder.

Translational psychiatry
Accurate differentiation of schizophrenia (SZ) and bipolar disorder (BD) is crucial for effective clinical management. However, current diagnostic methods, which rely heavily on subjective assessments, are prone to high rates of misdiagnosis. This st...

Reconfiguration of functional brain hierarchy in schizophrenia.

Translational psychiatry
The multidimensional nature of schizophrenia requires a comprehensive exploration of the functional and structural brain networks. While prior research has provided valuable insights into these aspects, our study goes a step further to investigate th...

Introducing e-Motions: a novel intraoperative test for social cognition mapping. Triple validation in normative, schizophrenia, and autism spectrum disorder populations.

Acta neurochirurgica
BACKGROUND: Social cognition is essential for daily functioning, as it influences quality of life, return to work, and interpersonal communication. While schizophrenia and autism spectrum disorder (ASD) have been the paradigmatic conditions in which ...

Neuromodulation and neural networks in psychiatric disorders: current status and emerging prospects.

Psychological medicine
Psychiatric disorders lead to disability, premature mortality and economic burden, highlighting the urgent need for more effective treatments. The understanding of psychiatric disorders as conditions of large-scale brain networks has created new oppo...

Functional Near-Infrared Spectroscopy in Schizophrenia Research: Progress, Challenges, and Future Directions.

Medical science monitor : international medical journal of experimental and clinical research
This review comprehensively examines the application and progress of functional near-infrared spectroscopy (fNIRS) in schizophrenia research. Schizophrenia is a complex neuropsychiatric disorder characterized by extensive dysfunction in the prefronta...

Enhancing schizophrenia diagnosis efficiency with EEGNet: a simplified recognition model based on γ band features.

Psychiatry research. Neuroimaging
OBJECTIVE: This study aims to develop an objective and efficient diagnostic model for schizophrenia (SCZ) by integrating electroencephalogram (EEG) signals with deep learning techniques. Building on previous research, γ wave activity is selected as a...

Exposotypes in psychotic disorders.

Scientific reports
Psychiatry lags in adopting etiological approaches to diagnosis, prognosis, and outcome prediction compared to the rest of medicine. Etiological factors such as childhood trauma (CHT), substance use (SU), and socioeconomic status (SES) significantly ...